BioMedNewsBreaks – Progressive Care Inc. (RXMD) Releases 2022 Annual Financial Results, Reports $40.6M Total Revenue
Progressive Care (OTCQB: RXMD), a personalized healthcare services and technology provider, is reporting financial results for the fiscal year ended Dec. 31, 2022. Highlights of the report include an increase in total revenue to $40.6 million, representing a 5% growth from the prior year, with pharmacy revenue increasing by $2.5 million, or 7%, and 340B contract revenue totaling $3.8 million for the year, an increase of $1 million from the year before. The company reported gross profit margin of approximately 24% in 2022, compared to approximately 26% in 2021, along with the completion of a capital raise with NextPlat Corp,…